Nvidia (NVDA) Invests $10.4M in Generate Biomedicines (GENB)

Nvidia (NASDAQ: NVDA) has invested approximately $10.4 million in Generate Biomedicines (NASDAQ: GENB), marking Generate as one of its top five largest holdings. Generate, which went public in February 2023, has seen its shares rise over 12% year-to-date. The company's AI platform aims to enhance the drug development process by creating new therapeutics, with its lead candidate in phase 3 trials for asthma. This investment indicates significant backing in a clinical-stage biotech with a broad pipeline, which could attract attention from prospective investors in the market.